News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
684,605 Results
Type
Article (40494)
Company Profile (210)
Press Release (643901)
Section
Business (205376)
Career Advice (1994)
Deals (35659)
Drug Delivery (77)
Drug Development (80865)
Employer Resources (167)
FDA (16086)
Job Trends (14950)
News (346502)
Policy (32844)
Tag
Academia (2609)
Africa (723)
Alliances (49701)
Alzheimer's disease (1137)
Antibody-drug conjugate (ADC) (44)
Approvals (16029)
Arizona (167)
Artificial intelligence (61)
Asia (37435)
Australia (6094)
Bankruptcy (354)
Best Places to Work (11265)
Biosimilars (58)
C2C Services and Suppliers (80085)
California (1270)
Canada (732)
Cancer (251)
Career advice (1668)
Cell therapy (87)
China (70)
Clinical research (62911)
Collaboration (84)
Colorado (44)
Connecticut (47)
COVID-19 (2511)
Cystic fibrosis (70)
Data (69)
Diabetes (50)
Diagnostics (6080)
Diversity, equity & inclusion (44)
Drug pricing (48)
Earnings (83846)
Employer resources (140)
Europe (80226)
Events (107896)
Executive appointments (61)
FDA (16187)
Florida (166)
Funding (66)
Gene therapy (64)
GLP-1 (495)
Government (4322)
Healthcare (18690)
Hotbed/Location (485068)
Idaho (56)
Illinois (211)
Indiana (120)
Infectious disease (2530)
Inflammatory bowel disease (84)
Interviews (309)
IPO (16211)
Job creations (3739)
Job search strategy (1437)
Kansas (90)
Layoffs (380)
Legal (7939)
Liver cancer (54)
Lung cancer (52)
Maine (48)
Management (52)
Manufacturing (59)
Maryland (302)
Massachusetts (1116)
Medical device (13045)
Medtech (13048)
Mergers & acquisitions (19193)
Metabolic disorders (191)
Michigan (104)
Minnesota (198)
Neuroscience (1230)
New Jersey (347)
New York (397)
NextGen Class of 2024 (6487)
Non-profit (4501)
North Carolina (537)
Northern California (618)
Obesity (122)
Ohio (89)
Opinion (165)
Pennsylvania (457)
People (56247)
Phase I (19503)
Phase II (27695)
Phase III (20720)
Postmarket research (2565)
Preclinical (8398)
Rare diseases (102)
Real estate (6087)
Recruiting (63)
Regulatory (21364)
Research institute (2361)
Resumes & cover letters (345)
South America (1115)
Southern California (537)
Startups (3595)
Texas (139)
United States (6250)
Vaccines (426)
Washington State (137)
Weight loss (106)
Date
Today (141)
Last 7 days (707)
Last 30 days (2542)
Last 365 days (38165)
2024 (23317)
2023 (40331)
2022 (51424)
2021 (56016)
2020 (54495)
2019 (46970)
2018 (35332)
2017 (32517)
2016 (31984)
2015 (38011)
2014 (31868)
2013 (26994)
2012 (29111)
2011 (29781)
2010 (27828)
684,605 Results for "braintree laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
July 16, 2024
·
4 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Biotech Bay
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.
May 19, 2024
·
4 min read
BioMidwest
Kraig Biocraft Laboratories Increases Spider Silk Production with Next Generation of Hybrid Eggs Completed
Kraig Biocraft Laboratories, Inc., announces that it has expanded its production of spider silk with the creation of the next generation of BAM-1 hybrid.
June 25, 2024
·
2 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
Business
Avantor® Appoints Corey Walker as President of Laboratory Solutions
Avantor, Inc. announced that Corey Walker has rejoined the company as President of Avantor’s Laboratory Solutions business, reporting to CEO Michael Stubblefield.
June 21, 2024
·
4 min read
Deals
Crescita to Acquire Strategic Assets of Occy Laboratory
Crescita Therapeutics Inc. today announced that it has agreed to acquire all of the non-real estate business assets of Occy Laboratory Inc., (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”).
June 20, 2024
·
5 min read
Deals
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
Crescita Therapeutics Inc. today announced that it has concluded the asset purchase agreement (the “Purchase Agreement”) to acquire all of the non-real estate business assets of Occy Laboratory Inc. (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”).
June 26, 2024
·
4 min read
1 of 68,461
Next
